Study

EORTC-2013-BTG

Observational study for assessing treatment and outcome of patients with primary brain tumours diagnosed according to cIMPACT-NOW recommendations and the 2021 WHO classification

Study documentation Back to result

Trial Status

Recruiting

Dates

Date of activation: 21-Mar-2023

Data management at EORTC

Yes

Design

Cohort
Not randomized / N.A.

Targeted Sample size

EORTC Groups: 6000 - All Groups: 6000

Treatment

None

Study Staff

  • Michael Weller (Study Coordinator), UniversitaetsSpital Zurich - Neurology Clinic, Zurich
  • Jose Casas (TR Scientist), EORTC Headquarters, Brussels
  • Corinne Daumer (Project Manager), EORTC Headquarters, Brussels
  • Florence Dujardin (Clinical Operations Manager), EORTC Headquarters, Brussels
  • Beatrice Fournier (Clinical Scientist), EORTC Headquarters, Brussels
  • Thierry Gorlia (Statistician), EORTC Headquarters, Brussels
  • Lore Hermans (Regulatory Affairs Manager), EORTC Headquarters, Brussels
  • Sven Janssen (Data Manager), EORTC Headquarters, Brussels
  • Matthias Preusser (Study Co-Coordinator, Y-ECI Coordinator), Universitaetsklinikum Wien - AKH unikliniken, Vienna
  • Caroline Quoilin (Clinical Scientist), EORTC Headquarters, Brussels
  • Ezrhiel Racelis (Clinical Operations Assistant), EORTC Headquarters, Brussels
  • Antimo Razzino (Data Manager), EORTC Headquarters, Brussels
  • Jose Silva (Clinical Research Physician), EORTC Headquarters, Brussels
  • Maarten Spruyt (Imaging DM, Data Manager), EORTC Headquarters, Brussels
  • Eliza Starczewska (Regulatory Affairs Manager, Junior RAM), EORTC Headquarters, Brussels

Type of cancer

  • Brain

Participating groups

  • EORTC Brain Tumor Group

Recruiting centers

  • A.O Landeskrankenhaus - Innsbruck Universitaetsklinik (Innsbruck, Austria)
  • APHP Sorbonne Univ - Hopital la Pitie-Salpetriere (PARIS, France)
  • AZ Delta - Campus Rumbeke (Roeselare, Belgium)
  • Azienda Ospedaliera Città della Salute e della Scienza di Torino - Ospedale San Giovanni - Dipartimento Neuroscienze (Torino, Italy)
  • C.H.U. Sart-Tilman (Liege, Belgium)
  • CHU Lyon - Hopital neurologique Pierre Wertheimer (BRON CEDEX, France)
  • Centre Hospitalier Universitaire Vaudois - Lausanne (Lausanne, Switzerland)
  • Centro Hospitalar Universitario Lisboa Norte - Hospital Sta. Maria (Lisboa, Portugal)
  • Diagnostic & Therapeutic Center of Athens Hygeia Hospital S.A. (Athens, Greece)
  • Erasmus MC (Rotterdam, Netherlands)
  • Hopital de La Timone (APHM) (MARSEILLE, France)
  • Hospital Clinic de Barcelona (Barcelona, Spain)
  • Hospital De La Santa Creu I Sant Pau (Barcelona, Spain)
  • ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) (Badalona - (Barcelona), Spain)
  • ICO L’Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) (L' Hospitalet De Llobregat, Spain)
  • IRCCS - Istituto Neurologico Carlo Besta (Milano, Italy)
  • IRCCS - Istituto Oncologico Veneto (Padova, Italy)
  • IRCCS--Ospedale Bellaria-Bologna (Bologna, Italy)
  • Institut Jules Bordet (Anderlecht, Belgium)
  • Instituto Portugues de Oncologia de Lisboa Francisco Gentil – EPE (Lisboa, Portugal)
  • Leiden University Medical Centre (Leiden, Netherlands)
  • Newcastle Hospitals NHS Trust - Freeman Hospital, Northern Centre For Cancer Care (Newcastle upon Tyne, United Kingdom)
  • Nottingham University Hospitals NHS Trust - City Hospital (Nottingham, United Kingdom)
  • Onze Lieve Vrouw Ziekenhuis (Aalst, Belgium)
  • Oslo University Hospital - Radiumhospitalet (Oslo, Norway)
  • The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands)
  • Univ. Knappschaft Krankenhaus Bochum (Bochum-Langendreer, Germany)
  • Univ. of Florence -Azienda Ospedaliero-Universitaria Careggi (Firenze, Italy)
  • UniversitaetsSpital Zurich - Neurology Clinic (Zurich, Switzerland)
  • Universitaetsklinikum - Essen (Essen, Germany)
  • Universitaetsklinikum Jena (Jena, Germany)
  • Universitaetsklinikum Koeln (Koeln, Germany)
  • Universitaetsklinikum Leipzig-Klinik fuer Strahlentherapie und Radioonkologie (Leipzig, Germany)
  • Universitaetsklinikum Regensburg (Regensburg, Germany)
  • Universitaetsklinikum Wien - AKH unikliniken (Vienna, Austria)
  • Universitair Ziekenhuis Brussel (Brussels, Belgium)
  • University Hospital Frankfurt -Senckenberg Institute of Neurooncology (Frankfurt am Main, Germany)

Centers to be activated

  • AUSL Bologna - Ospedale Bellaria (Bologna, Italy)
  • Azienda ospedaliero Univ Policlinico Umberto I (Roma, Italy)
  • IRCCS Ospedale San Raffaele (Milano, Italy)
  • IRCCS-Regina Elena National Cancer Center (Roma, Italy)
  • Institut de Cancerologie de l’Ouest (ICO) - Saint Herblain (Saint Herblain CEDEX, France)
  • NHS Lothian - The Royal Infirmary Of Edinburgh (Edinburgh, United Kingdom)
  • UMC-Academisch Ziekenhuis Utrecht (Utrecht, Netherlands)
  • Universitaetsklinikum Bonn (Bonn, Germany)
  • University Hospitals Bristol NHS Foundation Trust - Bristol Haematology And Oncology Centre (Bristol, United Kingdom)

Protocol summary

http://clinicaltrials.gov/study/NCT05259605

NCT number

NCT05259605